BRIDGEWAY CAPITAL MANAGEMENT, LLC - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 77 filers reported holding GLYCOMIMETICS INC in Q3 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2023$258,300
+9.2%
172,200
+26.7%
0.01%0.0%
Q2 2023$236,466
+70.0%
135,900
+23.1%
0.01%
+50.0%
Q1 2023$139,104
-42.9%
110,400
+37.3%
0.00%
-33.3%
Q4 2022$243,612
+183.3%
80,400
-48.3%
0.01%
+200.0%
Q3 2022$86,000
-7.5%
155,4000.0%0.00%0.0%
Q2 2022$93,000
-47.5%
155,4000.0%0.00%
-33.3%
Q1 2022$177,000
-21.0%
155,4000.0%0.00%
-25.0%
Q4 2021$224,000
-39.3%
155,400
-7.9%
0.00%
-42.9%
Q3 2021$369,000
-26.2%
168,700
-21.8%
0.01%
-22.2%
Q2 2021$500,000
-2.7%
215,700
+26.4%
0.01%
-10.0%
Q1 2021$514,000
-33.4%
170,700
-16.8%
0.01%
-37.5%
Q4 2020$772,000
+20.2%
205,200
-1.9%
0.02%
+6.7%
Q3 2020$642,000
-56.2%
209,100
-46.4%
0.02%
-50.0%
Q2 2020$1,466,000
+151.9%
390,000
+52.8%
0.03%
+130.8%
Q1 2020$582,000
+13.5%
255,200
+163.1%
0.01%
+85.7%
Q4 2019$513,000
-28.1%
97,000
-41.4%
0.01%
-30.0%
Q3 2019$713,000
+119.4%
165,400
+727.0%
0.01%
+233.3%
Q1 2018$325,000
-47.3%
20,000
-45.6%
0.00%
-57.1%
Q4 2017$617,000
-33.9%
36,764
-44.9%
0.01%
-36.4%
Q3 2017$934,000
+25.4%
66,7640.0%0.01%
+22.2%
Q2 2017$745,000
+105.2%
66,7640.0%0.01%
+125.0%
Q1 2017$363,000
-27.3%
66,764
-18.3%
0.00%
-42.9%
Q4 2016$499,000
-36.4%
81,764
-25.5%
0.01%
-41.7%
Q3 2016$785,000
-1.6%
109,7640.0%0.01%0.0%
Q2 2016$798,000
+22.0%
109,7640.0%0.01%
+9.1%
Q1 2016$654,000
+4.1%
109,7640.0%0.01%
-8.3%
Q4 2015$628,000
+59.8%
109,764
+56.2%
0.01%
+50.0%
Q3 2015$393,000
-18.0%
70,264
+16.6%
0.01%
-11.1%
Q2 2015$479,000
+52.1%
60,264
+59.2%
0.01%
+28.6%
Q1 2015$315,000
+47.9%
37,860
+28.0%
0.01%
+40.0%
Q4 2014$213,000
+33.1%
29,589
+28.6%
0.01%
+25.0%
Q3 2014$160,00023,0000.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
BVF INC/IL 3,229,856$45,186,0005.74%
NEA Management Company, LLC 8,584,128$120,092,0004.21%
NEXTHERA CAPITAL LP 321,286$4,495,0001.16%
Redmile Group, LLC 1,214,088$16,985,0000.84%
EAM Investors, LLC 371,030$5,191,0000.69%
Schonfeld Strategic Advisors LLC 500,104$6,996,0000.64%
ELEMENT CAPITAL MANAGEMENT LLC 29,909$418,0000.17%
Jafra Capital Management LP 16,839$236,0000.09%
PRENTISS SMITH & CO INC 20,000$280,0000.08%
Endurant Capital Management LP 17,607$246,0000.08%
View complete list of GLYCOMIMETICS INC shareholders